Treatment Conditions | ACP-103 Brain Level | Haloperidol Brain Level | |
---|---|---|---|
nmol/kg | |||
ACP-103 (0.0075) + vehicle | <4 | ||
ACP-103 (0.015) + vehicle | 5 ± 0.2 | ||
ACP-103 (0.03) + vehicle | 9 ± 1 | ||
ACP-103 (0.06) + vehicle | 11 ± 1 | ||
Vehicle + haloperidol (0.0075) | 16 ± 6 | ||
Vehicle + haloperidol (0.015) | 17 ± 5 | ||
Vehicle + haloperidol (0.03) | 29 ± 9 | ||
Vehicle + haloperidol (0.06) | 68 ± 22 | ||
ACP-103 (0.0075) + haloperidol (0.0075) | <4 | 17 ± 4 | |
ACP-103 (0.015) + haloperidol (0.015) | 6 ± 1 | 20 ± 7 | |
ACP-103 (0.03) + haloperidol (0.03) | 8 ± 1 | 44 ± 15 | |
ACP-103 (0.06) + haloperidol (0.06) | 19 ± 3 | 79 ± 27 |